An opinion on the commercial prospects of RHY, page-7

@Davisite

Apologies if I appeared haste to jump down your throat, however I feel you're just cherry picking info.

Yes, it appears they're intending to spend 1.98m this Qtr.

However what you failed to mention (intentionally or unintentionally - I'm not casting an aspersion either way) is that $1.35m of that spend this Qtr is on R&D.

AND... they will get 43% of the R&D spend back by way of a cash rebate via the ATO.

So - net net - they're going to spend 1.3m this Qtr

They started the Qtr with 7m, less 1.3m spend equals $5.7m. Then we add the $300k they received this Qtr from a R&D rebate - they should finish the Qtr with $6m cash

All I'm saying is that they launched the IPO last year with the intention to be fully funded to take the product to market & they are on track to achieve that goal.

2019 is the year of delivery.